下一代流行病学:高分辨率分子表型分析在糖尿病研究中的作用
本文综述了组学在糖尿病流行病学中的文献,讨论该领域如何演变。文章指出,可负担的高通量遗传和分子表型分析技术推动了更关注机制的新型流行病学出现,此类研究已识别基因变异或因果位点并关联其他组学数据以定义介导遗传变异对临床表型表达影响的分子过程。文章强调需将组学技术应用于设计良好的流行病学研究并仔细分析解释新兴数据。
要点
- 高通量遗传和分子表型分析技术推动了更关注机制的新型流行病学出现。
- 应用这些技术的研究已识别基因变异或因果位点,并关联其他组学数据以定义介导遗传变异对临床表型表达影响的分子过程。
- 需将组学技术应用于设计良好的流行病学研究,并仔细分析解释新兴数据。
核心结论
- 可将此视为下一代流行病学,需要将复杂高维数据分析方法与流行病学研究核心原则相结合。
研究设计与样本
- 综述文献,检索范围为糖尿病流行病学中的组学。
主要发现
- 应用高通量遗传和分子表型分析技术的研究已识别基因变异或因果位点,并关联其他组学数据以定义介导遗传变异对临床表型表达影响的分子过程。
- 这些流行病学研究的规模正迅速增长,随着公共和私营部门大力投资组学数据生成,这一趋势将持续。
- 许多人寄希望于大量多样分子数据在药物发现、预测对危险因素的敏感性、对治疗的反应和糖尿病并发症易感性以及开发疾病监测工具和替代结局方面取得突破。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Epidemiologists have for many decades reported on the patterns and distributions of diabetes within and between populations and have helped to elucidate the aetiology of the disease. This has helped raise awareness of the tremendous burden the disease places on individuals and societies; it has also identified key risk factors that have become the focus of diabetes prevention trials and helped shape public health recommendations. Recent developments in affordable high-throughput genetic and molecular phenotyping technologies have driven the emergence of a new type of epidemiology with a more mechanistic focus than ever before. Studies employing these technologies have identified gene variants or causal loci, and linked these to other omics data that help define the molecular processes mediating the effects of genetic variation in the expression of clinical phenotypes. The scale of these epidemiological studies is rapidly growing; a trend that is set to continue as the public and private sectors invest heavily in omics data generation. Many are banking on this massive volume of diverse molecular data for breakthroughs in drug discovery and predicting sensitivity to risk factors, response to therapies and susceptibility to diabetes complications, as well as the development of disease-monitoring tools and surrogate outcomes. To realise these possibilities, it is essential that omics technologies are applied to well-designed epidemiological studies and that the emerging data are carefully analysed and interpreted. One might view this as next-generation epidemiology, where complex high-dimensionality data analysis approaches will need to be blended with many of the core principles of epidemiological research. In this article, we review the literature on omics in diabetes epidemiology and discuss how this field is evolving. Graphical abstract.
引用
- Franks PW, Pomares-Millan H. Next-generation epidemiology: the role of high-resolution molecular phenotyping in diabetes research. Diabetologia. 2020. PMID: 32840675. doi:10.1007/s00125-020-05246-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。